Intradiscal Regenerative Therapies: State of the Art

Dr. Annu Navani presents innovative intradiscal regenerative therapies for spinal pain localized to the low back or spinal discs. Dr. Navani discusses the current market for stem cell therapies and investments in regenerative medicine companies that are sponsoring various clinical trials worldwide.

Title:

Intradiscal Regenerative Therapies: State of the Art

$3.75

Categories: ,

Intradiscal Regenerative Therapies: State of the Art

Published on May 02, 2022

Annu Navani, MD – Comprehensive Spine Sports Center

Dr. Annu Navani presents innovative intradiscal regenerative therapies for spinal pain localized to the low back or spinal discs. Dr. Navani discusses the current market for stem cell therapies and investments in regenerative medicine companies that are sponsoring various clinical trials worldwide. She describes studies focusing on mesenchymal stem cells (MSCs) and explains the need for advances in regenerative medicine for clinical applications in pain management and tissue repair. Dr. Navani also discusses the first ever head-to-head multi-center, randomized, placebo-controlled trial comparing platelet-rich plasma (PRP) or bone marrow concentrate (BMC) against a placebo for discogenic back pain, followed by the projected growth of regenerative therapies.

Description

Annu Navani, MD – Comprehensive Spine Sports Center

Dr. Annu Navani presents innovative intradiscal regenerative therapies for spinal pain localized to the low back or spinal discs. Dr. Navani discusses the current market for stem cell therapies and investments in regenerative medicine companies that are sponsoring various clinical trials worldwide. She describes studies focusing on mesenchymal stem cells (MSCs) and explains the need for advances in regenerative medicine for clinical applications in pain management and tissue repair. Dr. Navani also discusses the first ever head-to-head multi-center, randomized, placebo-controlled trial comparing platelet-rich plasma (PRP) or bone marrow concentrate (BMC) against a placebo for discogenic back pain, followed by the projected growth of regenerative therapies.

Reviews

There are no reviews yet.

Be the first to review “Intradiscal Regenerative Therapies: State of the Art”